Parasite and vector papers during the COVID-19 publication rush
The current endemic has changed a lot in academic publishing, resulting in the fast production of large quantities of texts concerning COVID-19 and the drop of…Read more »
The current endemic has changed a lot in academic publishing, resulting in the fast production of large quantities of texts concerning COVID-19 and the drop of…Read more »
The current COVID-19 pandemic has taken the spotlight in the news. Despite the seriousness of the situation, other health issues should not be forgotten. In…Read more »
Each year, millions of people worldwide still suffer from malaria and several hundreds of thousands die. There are several malaria vaccine candidates that could…Read more »
Quantitative HRP2 testing shows the potential to identify patients at high risk of developing cerebral malaria, whose treatment then could be adjusted…Read more »
Gametocytocidal drugs stop the malaria life cycle by preventing transmission from human to mosquito. This has the potential to contribute towards malaria…Read more »
We have won some significant victories against one of human’s greatest enemies, malaria, by targeting its vector. But are we doing enough, especially in…Read more »
Looking at several factors that have been influencing Lassa fever outbreaks in Nigeria shows that stopping the current outbreak will require more than rodent…Read more »
The Fyodor Urine Malaria Test (UMT) has the potential to improve patient outcome and reduce the spread of drug resistance in malaria. It does not require a…Read more »
Social media can be used to reduce malaria prevalence and mortality. It also facilitates new malaria innovations. On 16 November, six malaria activists won the…Read more »
In Edo State, Nigeria, health researchers are collecting data on Lassa fever to improve health education and protect people from getting infected.